Sophie Ferey
About Sophie Ferey
Sophie Ferey is a Chef De Produit Immuno Oncologie Cancer Du Rein at Bristol Myers Squibb, with a background in marketing, research, and design.
Title
Sophie Ferey is currently holding the title of Chef de produit immuno-oncologie cancer du rein at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Sophie Ferey began her current role at Bristol Myers Squibb as Chef de produit immuno-oncologie cancer du rein in December 2020. She actively manages product development and marketing strategies aimed at kidney cancer treatment within the immuno-oncology franchise.
Past Experience at Bristol Myers Squibb
Before her current role, Sophie worked as an Assistante chef de produit oncologie franchise Mélanome at Bristol Myers Squibb from 2019 to 2020. In this position, she was involved in marketing and product management for the melanoma oncology franchise in the Paris region.
Education and Expertise
Sophie Ferey holds an MSc in Etudes et Décision Marketing from NEOMA Business School, which she earned in 2020. She also completed a Master 2 in Nutrition, Qualité et Santé (NQS) from Sorbonne Universités in 2019. Her academic background includes a Master in Biologie intégrative et physiologie and a Licence in science de la vie et santé publique from Université Pierre et Marie Curie, as well as one year of medical studies at Faculté de médecine Pierre et Marie Curie.
Professional Background
Sophie Ferey has held various roles before her current position, including a stagiaire assistant de projet pedagogie et formation at Pileje, a partenaire de projet with Association LA DRECHERIE, and an assistant de recherche stagiaire at PHYSIOLOGIE DE LA NUTRITION ET DU COMPORTEMENT ALIMENTAIRE (PNCA)- INRA/AgroParisTech. She has also worked as a graphiste/ergonomiste under her own entrepreneurial venture from 2016 to 2019.
Interest in Scientific Innovation and Public Health
Sophie Ferey has a strong interest in scientific innovation and public health issues, which have significantly influenced her career path in the pharmaceutical industry. Her multidisciplinary skills stem from experiences in both fundamental research and marketing.